Аблация у пациентов с фибрилляцией предсердий и сниженной фракцией выброса левого желудочка: только улучшение гемодинамики или влияние на прогноз? (Систематический обзор)

Аблация у пациентов с фибрилляцией предсердий и сниженной фракцией выброса левого желудочка: только улучшение гемодинамики или влияние на прогноз? (Систематический обзор)

Автор: Канорский С.Г., Новиков Д.С.

Журнал: Патология кровообращения и кардиохирургия @journal-meshalkin

Рубрика: Обзоры

Статья в выпуске: 3 т.27, 2023 года.

Бесплатный доступ

Цель. Критически оценить результаты исследований аблации фибрилляции предсердий в отношении влияния на гемодинамику и прогноз у пациентов с сердечной недостаточностью со сниженной фракцией выброса левого желудочка. Методы. В базах данных PubMed, Embase, Cochrane Library и Web of Science по ключевым словам отбирали наиболее цитируемые исследования, содержащие данные о лечении больных фибрилляцией предсердий и сердечной недостаточностью со сниженной фракцией выброса с помощью аблации, включая показатели фракции выброса левого желудочка, смертности, других конечных точек терапии. Анализировали влияние аблации в сравнении с медикаментозной терапией на динамику фракции выброса левого желудочка и клинические исходы у пациентов с фибрилляцией предсердий. Результаты. Провели скрининг 4 581 источника литературы, 48 из них отобрали для цитирования в обзоре. После эндокардиальной катетерной аблации, торакоскопической или гибридной аблации фибрилляции предсердий наблюдается в 4 раза большее (p

Еще

Катетерная аблация, сердечная недостаточность, сниженная фракция выброса левого желудочка, торакоскопическая аблация, фибрилляция предсердий

Короткий адрес: https://sciup.org/142239088

IDR: 142239088   |   DOI: 10.21688/1681-3472-2023-3-7-18

Список литературы Аблация у пациентов с фибрилляцией предсердий и сниженной фракцией выброса левого желудочка: только улучшение гемодинамики или влияние на прогноз? (Систематический обзор)

  • Chiocchini A., Terricabras M., Verma A. Atrial fibrillation ablation in heart failure: What do we know? What can we do? Europace. 2021;23(3):353-361. PMID: 33083820. https://doi. org/10.1093/europace/euaa217
  • Capucci A., Stronati G., Guerra F. Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments. Eur Heart JSuppl. 2023;25(Suppl C):C12-C14. PMID: 37125269; PMCID: PMC10132592. https://doi.org/10.1093/eurheartjsupp/suad033
  • Wazni O.M., Dandamudi G., Sood N., Hoyt R., Tyler J., Durrani S., Niebauer M., Makati K., Halperin B., Gauri A., Morales G., Shao M., Cerkvenik J., Kaplon R.E., Nissen S.E.; STOP AF First Trial Investigators. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021;384(4):316-324. PMID: 33197158. https://doi.org/10.1056/NEJMoa2029554
  • Andrade J.G., Wells G.A., Deyell M.W., Bennett M., Essebag V., Champagne J., Roux J.-F., Yung D., Skanes A., Khaykin Y., Morillo C., Jolly U., Novak P., Lockwood E., Amit G., Angaran P., Sapp J., Wardell S., Lauck S., Macle L., Verma A.; EARLY-AF Investigators. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384(4):305-315. PMID: 33197159. https://doi.org/10.1056/NEJMoa2029980
  • Hsu J.C., Darden D., Du C., Marine J.E., Nichols S., Marcus G.M., Natale A., Noseworthy P.A., Selzman K.A., Varosy P., Masoudi F., Freeman J., Curtis J., Akar J., Kowey P.R. Initial findings from the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures. J Am Coll Cardiol. 2023;81(9):867-878. PMID: 36858707. https://doi.org/10.1016/j.jacc.2022.11.060
  • Younes H., Noujaim C., Mekhael M., Chouman N., Assaf A., Kreidieh O., Lim C., Marrouche N., Donnellan E. Atrial fibrillation ablation as first-line therapy for patients with heart failure with reduced ejection fraction (HFrEF): evaluating the impact on patient survival. Expert Rev Cardiovasc Ther. 2023;21(2):111-121. PMID: 36680789. https://doi.org/10.1080 /14779072.2023.2172402
  • MacDonald M.R., Connelly D.T., Hawkins N.M., Steedman T., Payne J., Shaw M., Denvir M., Bhagra S., Small S., Martin W., McMurray J.J.V., Petrie M.C. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97(9):740-747. PMID: 21051458. https://doi.org/10.1136/hrt.2010.207340
  • Jones D.G., Haldar S.K., Hussain W., Sharma R., Francis D.P., Rahman-Haley S.L., McDonagh T.A., Underwood S.R., Markides V., Wong T. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61(18):1894-1903. PMID: 23500267. https://doi. org/10.1016/j.jacc.2013.01.069
  • Hunter R.J., Berriman T.J., Diab I., Kamdar R., Richmond L., Baker V., Goromonzi F., Sawhney V., Duncan E., Page S.P., Ullah W., Unsworth B., Mayet J., Dhinoja M., Earley M.J., Sporton S., Schilling R.J. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7(1 ):31-38. PMID: 24382410. https://doi. org/10.1161/CIRCEP.113.000806
  • Di Biase L., Mohanty P., Mohanty S., Santangeli P., Trivedi C., Lakkireddy D., Reddy M., Jais P., Themistoclakis S., Dello Russo A., Casella M., Pelargonio G., Narducci M.L., Schweikert R., Neuzil P., Sanchez J., Horton R., Beheiry S., Hongo R., Hao S., Rossillo A., Forleo G., Tondo C., Burkhardt J.D., Haissaguerre M., Natale A. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637-1644. PMID: 27029350. https:// doi.org/10.1161/CIRCULATI0NAHA.115.019406
  • Prabhu S., Taylor A.J., Costello B.T., Kaye D.M., McLellan A.J.A., Voskoboinik A., Sugumar H., Lockwood S.M., Stokes M.B., Pathik B., Nalliah CJ., Wong G.R., Azzopardi S.M., Gutman S.J., Lee G., Layland J., Mariani J.A., Ling L.-H., Kalman J.M., Kistler P.M. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70(16):1949-1961. PMID: 28855115. https://doi.org/10.1016/_i.jacc.2017.08.041
  • Marrouche N.F., Brachmann J., Andresen D., Siebels J., Boersma L., Jordaens L., Merkely B., Pokushalov E., Sanders P., Proff J., Schunkert H., Christ H., Vogt J., Bänsch D.; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417-427. PMID: 29385358. https://doi.org/10.1056/NEJMoa1707855
  • Sohns C., Zintl K., Zhao Y., Dagher L., Andresen D., Siebels J., Wegscheider K., Sehner S., Boersma L., Merkely B., Pokushalov E., Sanders P., Schunkert H., Bänsch D., Mahnkopf C., Brachmann J., Marrouche N.F. Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure: CASTLE-AF trial. Circ Arrhythm Electrophysiol. 2020;13(10):e008461. PMID: 32903044. https://doi.org/10.1161/CIRCEP.120.008461
  • Noseworthy P.A., Van Houten H.K., Gersh B.J., Packer D.L., Friedman P.A., Shah N.D., Dunlay S.M., Siontis K.C., Piccini J.P., Yao X. Generalizability of the CASTLE-AF trial: catheter ablation for patients with atrial fibrillation and heart failure in routine practice. Heart Rhythm. 2020;17(7):1057-1065. PMID: 32145348; PMCID: PMC7648571. https://doi.org/10.1016XI. hrthm.2020.02.030
  • Parkash R., Wells G.A., Rouleau J., Talajic M., Essebag V., Skanes A., Wilton S.B., Verma A., Healey J.S., Sterns L., Bennett M., Roux J.-F., Rivard L., Leong-Sit P., Jensen-Urstad M., Jolly U., Philippon F., Sapp J.L., Tang A.S.L. Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial. Circulation. 2022;145(23):1693-1704. PMID: 35313733. https://doi. org/10.1161/CIRCULATI0NAHA.121.057095
  • Shiraishi Y., Kohsaka S., Ikemura N., Kimura T., Katsumata Y., Tanimoto K., Suzuki M., Ueda I., Fukuda K., Takatsuki S. Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study. Europace. 2023;25(1):83-91. PMID: 35851807; PMCID: PMC10103568. https://doi.org/10.1093/europace/euac108
  • von Olshausen G., Benson L., Dahlstrom U., Lund L.H., Savarese G., Braunschweig F. Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry. Eur J Heart Fail. 2022;24(9):1636-1646. PMID: 35779270. https://doi. org/10.1002/ejhf.2604
  • Virk S.A., Bennett R.G., Chow C., Sanders P., Kalman J.M., Thomas S., Kumar S. Catheter ablation versus medical therapy for atrial fibrillation in patients with heart failure: a meta-analysis of randomised controlled trials. Heart Lung Circ. 2019;28(5):707-718. PMID: 30509786. https://doi. org/10.1016/j.hlc.2018.10.022
  • Magnocavallo M., Parlavecchio A., Vetta G., Gianni C., Polselli M., De Vuono F., Pannone L., Mohanty S., Cauti F.M., Caminiti R., Miraglia V., Monaco C., Chierchia G.-B., Rossi P., Di Biase L., Bianchi S., de Asmundis C., Natale A., Della Rocca D.G. Catheter ablation versus medical therapy of atrial fibrillation in patients with heart failure: an updated systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2022;11(19):5530. PMID: 36233407; PMCID: PMC9572511. https://doi.org/10.3390/jcm11195530
  • Simader F.A., Howard J.P., Ahmad Y., Saleh K., Naraen A., Samways J.W., Mohal J., Reddy R.K., Kaza N., Keene D., Shun-Shin M.J., Francis D.P., Whinnett Z.I., Arnold A.D. Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials. Europace. 2023;25(2):341-350. PMID: 36305545; PMCID: PMC9934993. https://doi. org/10.1093/europace/euac173
  • Yu Z., Xing Y., Peng J., Xu B., Qi Y., Zheng Z., Qiu Y., Qiu F., Peng F. Catheter ablation versus medical therapy for atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials. Anatol J Cardiol. 2022;26(9):685-695. PMID: 35949135; PMCID: PMC9524201. https://doi.org/10.5152/ AnatolJCardiol.2022.1826
  • Romero J., Gabr M., Alviz I., Briceno D., Diaz J.C., Rodriguez D., Patel K., Polanco D., Trivedi C., Mohanty S., Della Rocca D., Lakkireddy D., Natale A., Di Biase L. Improved survival in patients with atrial fibrillation and heart failure undergoing catheter ablation compared to medical treatment: A systematic review and meta-analysis of randomized controlled trials. JCardiovascElectrophysiol. 2022;33(11):2356-2366. PMID: 35842804. https://doi.org/10.1111/jce.15622
  • Jaylik F., Qnar T., Akbulut T., Hayiroglu M.i. Comparison of catheter ablation and medical therapy for atrial fibrillation in heart failure patients: A meta-analysis of randomized controlled trials. Heart Lung. 2023;57:69-74. PMID: 36084398. https://doi.org/10.1016/j.hrtlng.2022.08.012
  • Calvert P., Farinha J.M., Gupta D., Kahn M., Proietti R., Lip G.Y.H. A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure. Expert Rev Cardiovasc Ther. 2022;20(3):169-183. PMID: 35255780. https://doi.org/10. 1080/14779072.2022.2050695
  • Mulder B.A., Rienstra M., Van Gelder I.C., Blaauw Y. Update on management of atrial fibrillation in heart failure: a focus on ablation. Heart. 2022;108(6):422-428. PMID: 34088767; PMCID: PMC8899490. https://doi.org/10.1136/heartjnl-2020-318081
  • Reddy Y.N.V., Borlaug B.A., Gersh B.J. Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction. Circulation. 2022;146(4):339-357. PMID: 35877831. https://doi.org/10.1161/ CIRCULATI0NAHA.122.057444
  • Cox J.L., Churyla A., Malaisrie S.C., Kruse J., Pham D.T., Kislitsina O.N., McCarthy P.M. When is a Maze procedure a Maze procedure? Can J Cardiol. 2018;34(11):1482-1491. PMID: 30121148. https://doi.org/10.1016/j.cjca.2018.05.008
  • Khiabani A.J., MacGregor R.M., Bakir N.H., Manghelli J.L., Sinn L.A., Maniar H.S., Moon M.R., Schuessler R.B., Melby S.J., Damiano R.J. Jr. The long-term outcomes and durability of the Cox-Maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2022;163(2):629-641.e7. PMID: 32563577; PMCID: PMC9810144. https://doi.org/10.1016/j. jtcvs.2020.04.100
  • Ad N., Henry L., Hunt S. The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation. Eur J Cardiothorac Surg. 2011;40(1):70-76. PMID: 21169029. https://doi.org/10.1016/j.ejcts.2010.11.016
  • Khan M.N., Ja'i's P., Cummings J., Di Biase L., Sanders P., Martin D.O., Kautzner J., Hao S., Themistoclakis S., Fanelli R., Potenza D., Massaro R., Wazni O., Schweikert R., Saliba W., Wang P., Al-Ahmad A., Beheiry S., Santarelli P., Starling R.C., Dello Russo A., Pelargonio G., Brachmann J., Schibgilla V., Bonso A., Casella M., Raviele A., Ha'ssaguerre M., Natale A.; PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008;359(17):1778-1785. PMID: 18946063. https://doi. org/10.1056/NEJMoa0708234
  • Hindricks G., PotparaT., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C., Boriani G., Castella M., Dan G.-A., Dilaveris P.E., Fauchier L., Filippatos G., Kalman J.M., La Meir M., Lane D.A., Lebeau J.-P., Lettino M., Lip G.Y.H., Pinto F.J., Thomas G.N., Valgimigli M., Van Gelder I.C., Van Putte B.P., Watkins C.L.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. PMID: 32860505. https://doi. org/10.1093/eurheartj/ehaa612
  • Phan K., Phan S., Thiagalingam A., Medi C., Yan T.D. Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation. Eur J Cardiothorac Surg. 2016;49(4):1044-1051. PMID: 26003961. https://doi.org/10.1093/ejcts/ ezv180
  • Haldar S., Khan H.R., Boyalla V., Kralj-Hans I., Jones S., Lord J., Onyimadu O., Satishkumar A., Bahrami T., De Souza A., Clague J.R., Francis D.P., Hussain W., Jarman J.W., Jones D.G., Chen Z., Mediratta N., Hyde J., Lewis M., Mohiaddin R., SalukheT.V., Murphy C., Kelly J., Khattar R.S., Toff W.D., Markides V., McCready J., Gupta D., Wong T. Catheter ablation vs. thoracoscopic surgical ablation in longstanding persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41(47):4471-4480. PMID: 32860414; PMCID: PMC7767634. https://doi.org/10.1093/ eurheartj/ehaa658
  • Kim H.R., Jeong D.-S., Kwon H.-J., Park S.-J., Park K.-M., Kim J.S., On Y.K. Total thoracoscopic ablation in patients with atrial fibrillation and left ventricular dysfunction. JTCVS Tech. 2021;8:60-66. PMID: 34401814; PMCID: PMC8350785. https:// doi.org/10.1016/Mtc.2021.04.006
  • Vos L.M., Kotecha D., Geuzebroek G.S.C., Hofman F.N., van Boven W.J.P., Kelder J., de Mol B.A.J.M., van Putte B.P. Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis. Europace. 2018;20(11 ):1790-1797. PMID: 29361045; PMCID: PMC6212776. https://doi.org/10.1093/ europace/eux385
  • Bisleri G., Pandey A.K., Verma S., Ali Hassan S.M., Yanagawa B., Khandaker M., Gaudino M., Russo A.M., Verma A., Bhatt D.L., Ha A.C.T. Combined minimally invasive surgical and percutaneous catheter ablation of atrial fibrillation: JACC review topic of the week. J Am Coll Cardiol. 2023;81(6):606-619. PMID: 36754519. https://doi.org/10.1016/j.jacc.2022.11.039
  • Kiankhooy A., Pierce C., Burk S., Phillips A., Eisenberg S., Dunnington G. Hybrid ablation of persistent and longstanding persistent atrial fibrillation with depressed ejection fraction: A single-center observational study. JTCVS Open. 2022;12:137-146. PMID: 36590727; PMCID: PMC9801285. https://doi.org/10.1016/j.xjon.2022.08.014
  • Camm A.J., Naccarelli G.V., Mittal S., Crijns H.J.G.M., Hohnloser S.H., Ma C.-S., Natale A., Turakhia M.P., Kirchhof P. The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79(19):1932-1948. PMID: 35550691. https://doi. org/10.1016/j.jacc.2022.03.337
  • Kirchhof P., Camm A.J., Goette A., Brandes A., Eckardt L., Elvan A., Fetsch T., van Gelder I.C., Haase D., Haegeli L.M., Hamann F., Heidbüchel H., Hindricks G., Kautzner J., Kuck K.-H., Mont L., Ng G.A., Rekosz J., Schoen N., Schotten U., Suling A., Taggeselle J., Themistoclakis S., Vettorazzi E., Vardas P., Wegscheider K., Willems S., Crijns H.J.G.M., Breithardt G.; EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305-1316. PMID: 32865375. https://doi. org/10.1056/NEJMoa2019422
  • Rillig A., Magnussen C., Ozga A.-K., Suling A., Brandes A., Breithardt G., Camm A.J., Crijns H.J.G.M., Eckardt L., Elvan A., Goette A., Gulizia M., Haegeli L., Heidbuchel H., Kuck K.-H., Ng A., Szumowski L., van Gelder I., Wegscheider K., Kirchhof P. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation. 2021;144(11):845-858. PMID: 34328366; PMCID: PMC8456351. https://doi.org/10.1161/ CIRCULATI0NAHA.121.056323
  • January C.T., Wann L.S., Calkins H., Chen L.Y., Cigarroa J.E., Cleveland J.C. Jr, Ellinor P.T., Ezekowitz M.D., Field M.E., Furie K.L., Heidenreich P.A., Murray K.T., Shea J.B., Tracy C.M., Yancy C.W. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125-e151. PMID: 30686041. https:// doi.org/10.1161/CIR.0000000000000665
  • McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Celutkienè J., Chioncel O., Cleland J.G.F., Coats A.J.S., Crespo-Leiro M.G., Farmakis D., Gilard M., Heymans S., Hoes A.W., Jaarsma T., Jankowska E.A., Lainscak M., Lam C.S.P., Lyon A.R., McMurray J.J.V., Mebazaa A., Mindham R., Muneretto C., Francesco Piepoli M., Price S., Rosano G.M.C., Ruschitzka F., Kathrine Skibelund A.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. PMID: 34447992. https://doi.org/10.1093/eurheartj/ehab368
  • Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun JJ., Colvin M.M., Deswal A., Drazner M.H., Dunlay S.M., Evers L.R., Fang J.C., Fedson S.E., Fonarow G.C., Hayek S.S., Hernandez A.F., Khazanie P., Kittleson M.M., Lee C.S., Link M.S., Milano C.A., Nnacheta L.C., Sandhu A.T., Stevenson L.W., Vardeny O., Vest A.R., Yancy C.W. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876-e894. PMID: 35363500. https:// doi.org/10.1161/CIR.0000000000001062
  • Packer M., Kowey P.R. Building castles in the sky: catheter ablation in patients with atrial fibrillation and chronic heart failure. Circulation. 2018;138(8):751-753. PMID: 29848750. https://doi.org/10.1161/CIRCULATI0NAHA.118.034583
  • Kuck K.-H., Merkely B., Zahn R., Arentz T., Seidl K., Schlüter M., Tilz R.R., Piorkowski C., Gellér L., Kleemann T., Hindricks G. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol. 2019;12(12):e007731. PMID: 31760819. https://doi. org/10.1161/CIRCEP.119.007731
  • Palmas F., Noviello C., Bo M. Atrial fibrillation in heart failure: drugs or ablation? Eur Heart J Suppl. 2023;25(Suppl B):B28-B30. PMID: 37091661; PMCID: PMC10120957. https://doi. org/10.1093/eurheartjsupp/suad063
  • Sugumar H., Prabhu S., Costello B., Chieng D., Azzopardi S., Voskoboinik A., Parameswaran R., Wong G.R., Anderson R., Al-Kaisey A.M., Ling L.-H., Kotschet E., Taylor A.J., Kalman J.M., Kistler P.M. Catheter ablation versus medication in atrial fibrillation and systolic dysfunction: late outcomes of CAMERA-MRI study. JACC Clin Electrophysiol. 2020;6(13):1721-1731. PMID: 33334453. https://doi.org/10.1016/j.jacep.2020.08.019
  • Verma A., Haines D.E., Boersma L.V., Sood N., Natale A., Marchlinski F.E., Calkins H., Sanders P., Packer D.L., Kuck K.-H., Hindricks G., Onal B., Cerkvenik J., Tada H., DeLurgio D.B.; PULSED AF Investigators. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation. 2023;147(19):1422-1432. PMID: 36877118; PMCID: PMC10158608. https://doi.org/10.1161/ CIRCULATI0NAHA.123.063988
Еще
Статья обзорная
SciUp 2024 © 2024 ©